ORCHESTRA BIOMED ($OBIO) is expected to release its quarterly earnings data on Friday, May 9th after market close, per Finnhub. Analysts are expecting revenue of $577,116 and earnings of -$0.49 per share.
You can see Quiver Quantitative's $OBIO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ORCHESTRA BIOMED Insider Trading Activity
ORCHESTRA BIOMED insiders have traded $OBIO stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $OBIO stock by insiders over the last 6 months:
- INVESTMENTS, LP RTW has made 2 purchases buying 99,900 shares for an estimated $275,701 and 0 sales.
- DAVID P HOCHMAN (See Remarks) has made 2 purchases buying 9,000 shares for an estimated $43,190 and 0 sales.
- ANDREW LAWRENCE TAYLOR (Chief Financial Officer) purchased 1,000 shares for an estimated $4,830
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ORCHESTRA BIOMED Hedge Fund Activity
We have seen 31 institutional investors add shares of ORCHESTRA BIOMED stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- IFP ADVISORS, INC added 83,481 shares (+106.4%) to their portfolio in Q1 2025, for an estimated $357,298
- JPMORGAN CHASE & CO added 38,535 shares (+354.5%) to their portfolio in Q4 2024, for an estimated $154,140
- BLACKROCK, INC. removed 33,174 shares (-1.7%) from their portfolio in Q1 2025, for an estimated $141,984
- PRICE T ROWE ASSOCIATES INC /MD/ removed 25,493 shares (-5.0%) from their portfolio in Q4 2024, for an estimated $101,972
- MILLENNIUM MANAGEMENT LLC added 21,513 shares (+inf%) to their portfolio in Q4 2024, for an estimated $86,052
- GOLDMAN SACHS GROUP INC added 20,098 shares (+47.8%) to their portfolio in Q4 2024, for an estimated $80,392
- JANE STREET GROUP, LLC removed 19,070 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $76,280
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ORCHESTRA BIOMED Analyst Ratings
Wall Street analysts have issued reports on $OBIO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- H.C. Wainwright issued a "Buy" rating on 04/23/2025
- BTIG issued a "Buy" rating on 03/20/2025
- Barclays issued a "Overweight" rating on 01/02/2025
To track analyst ratings and price targets for ORCHESTRA BIOMED, check out Quiver Quantitative's $OBIO forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
